Medicine & Health

Researchers at WashU have developed vulnerability maps highlighting regions across the United States with varying levels of socioeconomic vulnerability to influenza-like illness.

WashU Medicine researchers engineered a new cellular immunotherapy that turns brain cells called astrocytes into super cleaners, efficiently removing amyloid beta plaques from the brains of mice.

Public health scholar and entrepreneur Joseph T. Steensma bridges research and real-world impact, translating science into scalable solutions that address environmental and population health challenges.

During WashU Medicine’s 2026 Martin Luther King Jr. Commemoration Week, 22 faculty, staff and students were recognized with Drum Major Awards for embodying King’s work and words.

The annual Assistive Tech Make-a-Thon brings together WashU OT and engineering students to enhance the lives of St. Louisans who have disabilities.

WashU Medicine researchers have shown in a new study that GLP-1 medications, typically used for diabetes and weight loss, may be effective at treating and preventing substance use disorders, from alcohol to cigarettes to opioids.

WashU Olin Business School will host its annual spring symposium, aimed at improving health outcomes. The daylong event offers participants business-driven perspectives on health and the chance to connect with peers from WashU and beyond.

The 16th annual St. Louis Area Brain Bee drew 54 high school students from about 30 schools to WashU for a day of neuroscience challenges and panels.

The 2026-28 Carol B. and Jerome T. Loeb Teaching Fellows at WashU Medicine have been named. They are Salim Chahin, MD (left), an associate professor of neurology, and Ram K. Rohatgi, MD, an assistant professor of pediatrics and of radiology.

A mobile app developed by WashU Medicine researchers is effective at helping patients with substance use disorder who are in unstable housing situations take steps toward recovery, a new study found.